Quant Mid Cap Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 25-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate capital appreciation & provide longterm growth opportunities by investing in a portfolio of Mid Cap companies. There is no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Quant Mid Cap Fund-Growth Option-Direct Plan 1.17 23.32 34.43 11.80 12.96 12.88
Nifty Midcap 150 4.28 22.77 19.60 3.32 N/A 6.81

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Quant Mid Cap Fund-Growth Option-Direct Plan Jan 07, 2013 34.43 11.80 12.96 0.57 26.13
HDFC Mid Cap Opportunities Fund -Direct Plan - Growth Option Dec 31, 2012 18.97 4.25 14.58 1.09 24,714.42
DSP Midcap Fund - Direct Plan - Growth Dec 31, 2012 19.35 8.43 16.92 0.86 9,822.97
Kotak Emerging Equity Scheme - Growth - Direct Jan 01, 2013 18.08 8.20 17.42 0.59 9,016.03
Axis Midcap Fund - Direct Plan - Growth Jan 01, 2013 23.50 15.35 18.06 0.54 8,514.60
Nippon India Growth Fund - Direct Plan Growth Plan - Growth Jan 01, 2013 18.73 7.14 15.18 1.27 8,187.72

Fund Holdings as on 31-December-2020

  • Fortis Healthcare Ltd

  • Godrej Agrovet Limited

  • Aarti Industries Ltd

  • Alembic Pharmaceuticals Limited

  • Sun Pharmaceuticals Industries Ltd

  • Stylam Industries Limited

  • Adani Enterprises Ltd

  • Mphasis Ltd

  • PI Industries Ltd

  • Hindustan Aeronautics Limited

  • Zydus Wellness Ltd

  • L&T Technology Services Limited

  • Jubilant Life Sciences Ltd

  • Adani Ports & Special Economic Zone Ltd

  • Bharat Rasayan Limited

  • HCL Technologies Ltd.

  • Infosys Ltd.

  • Tata Elxsi Limited

  • Oracle Financial Services Software Ltd

  • Divis Laboratories Ltd.

  • TREPS

  • Mind Tree Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • NCA-NET CURRENT ASSETS

View More
  • Pharmaceuticals & Drugs

  • IT - Software

  • Consumer Food

  • Hospital & Healthcare Services

  • Pesticides & Agrochemicals

  • Chemicals

  • Laminates/Decoratives

  • Trading

  • Airlines

  • Engineering

  • Port

  • Insurance

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Quant Mid Cap Fund

NULL

Scheme Analysis

Quant Mid Cap Fund is a Equity - Mid Cap Fund fund and belongs to Quant Mutual Fund. It was launched on 07-Jan-2013 and currently has an AUM of ₹26.13 crore. Quant Mid Cap Fund is benchmarked against Nifty Midcap 150 as primary index.

The NAV of Quant Mid Cap Fund ended down ₹-1.1(-1.33%)yesterday to ₹81.1978.

Among its top 3 holdings the fund has exposure to Fortis Healthcare Ltd, and

The Quant Mid Cap Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432